Cargando…
Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
BACKGROUND: Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very limited in bladder cancer. RESULTS: We created the Genomics of Drug Sensitivity in Bladder...
Autores principales: | Ansari, Adnan Ahmad, Park, Inkeun, Kim, Inki, Park, Sojung, Ahn, Sung-Min, Lee, Jae-lyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171176/ https://www.ncbi.nlm.nih.gov/pubmed/30285760 http://dx.doi.org/10.1186/s12920-018-0406-2 |
Ejemplares similares
-
Cohort profile: King’s Health Partners bladder cancer biobank
por: Kotecha, Pinky, et al.
Publicado: (2020) -
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues
por: Shoaib, Muhammad, et al.
Publicado: (2019) -
An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer
por: Dancik, Garrett M.
Publicado: (2015) -
The Cancer Omics Atlas: an integrative resource for cancer omics annotations
por: Sun, Qingrong, et al.
Publicado: (2018) -
Concurrent Bladder Lymphoma and Bladder Cancer Presenting as Metastatic Bladder Cancer
por: Kim, Jae Heon, et al.
Publicado: (2012)